Advertisement

Quality of Life Research

, Volume 28, Issue 12, pp 3273–3279 | Cite as

Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes

  • Zheng Kang Lum
  • Melanie Yee Lee Siaw
  • Michelle Jia Xin Lee
  • Zexuan Koh
  • Parry Quan Zhang
  • Soo Kiang Eng
  • Swee Chin Tan
  • Joyce Yu-Chia LeeEmail author
Article

Abstract

Purpose

Mental well-being among community-dwelling individuals with type 2 diabetes has not been well established. The primary objective was to evaluate the change in the mental well-being of individuals with diabetes. The secondary objective was to evaluate the association between changes in mental well-being and perceived health over 6 months, and any interacting factors in this association.

Methods

This was a prospective, multicenter study. Community-dwelling individuals aged ≥ 21 years with type 2 diabetes were invited to meet with community pharmacists monthly for 6 months. Individuals who were unable to converse independently were excluded. A 12-item General Health Questionnaire (GHQ), measuring mental well-being was administered at baseline, and after 3 and 6 months. Perception of health was measured using the visual analog scale (VAS) of the EuroQoL 5-Dimension tool. Linear mixed model was used to analyze the change in mean GHQ and VAS scores. Association between the changes in GHQ and VAS scores was determined, and moderation analysis was conducted to elucidate the interacting variables of this association.

Results

Ninety-six individuals (82.4%) were included for analysis. The mean age was 60.3 years with a baseline mean HbA1c of 7.6%. A mean GHQ score reduction of 1.36 (p = 0.022) was observed. This reduction of mean GHQ score was associated with the change in mean VAS score. Having a duration of diabetes diagnosis of < 3.2 years was identified as moderator of this association.

Conclusion

Effective integrated pharmaceutical care with individualized counseling on lifestyle management appeared to improve the mental health of community-dwelling individuals with diabetes on top of glycemic control.

Keywords

Community pharmacy Mental well-being Pharmaceutical care Quality of life Diabetes 

Notes

Acknowledgements

The authors would like to thank the participating community retail pharmacists, Jaclyn Hwei, Mariana Mohamed, Linda Nathan, Ivan Ng, and Mandy Tam for volunteering their time to care for the patients in this study. The authors would also like to thank general physician Siew Meng Cheong for his advisory support in the study workflow, and Ms. Yiam Moi Chan for her administrative support.

Funding

The study was partially funded by the Alice Lim Grant (Singapore), and the glucose meters were donated by Johnson & Johnson Pte. Ltd. (Singapore).

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the National University of Singapore Institutional Review Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Hepler, C. D., & Strand, L. M. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Health-System Pharmacy,47, 533–543.CrossRefGoogle Scholar
  2. 2.
    McAllister, M., Dunn, G., Payne, K., et al. (2012). Patient empowerment: The need to consider it as a measurable patient-reported outcome for chronic conditions. BMC Health Services Research,12, 157.  https://doi.org/10.1186/1472-6963-12-157.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Blackburn, D. F., Yakiwchuk, E. M., Jorgenson, D. J., & Mansell, K. D. (2012). Proposing a redefinition of pharmaceutical care. Annals of Pharmacotherapy,46, 447–449.  https://doi.org/10.1345/aph.1Q585.CrossRefPubMedGoogle Scholar
  4. 4.
    Carollo, A., Rieutord, A., Launay-Vacher, V., & European Society of Clinical Pharmacy. (2012). European Society of Clinical Pharmacy (ESCP) glossary of scientific terms: A tool for standardizing scientific jargon. International Journal of Clinical Pharmacy,34, 263–268.  https://doi.org/10.1007/s11096-012-9619-1.CrossRefPubMedGoogle Scholar
  5. 5.
    Awad, A., Al-Ebrahim, S., & Abahussain, E. (2006). Pharmaceutical care services in hospitals of Kuwait. Journal of Pharmacy & Pharmaceutical Sciences,9, 149–157.Google Scholar
  6. 6.
    Brulhart, M. I., & Wermeille, J. P. (2011). Multidisciplinary medication review: Evaluation of a pharmaceutical care model for nursing homes. International Journal of Clinical Pharmacy,33, 549–557.  https://doi.org/10.1007/s11096-011-9506-1.CrossRefPubMedGoogle Scholar
  7. 7.
    Geurts, M. M. E., Stewart, R. E., Brouwers, J. R. B. J., et al. (2016). Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder. International Journal of Clinical Pharmacy,38, 808–815.  https://doi.org/10.1007/s11096-016-0281-x.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Finkers, F., Maring, J. G., Boersma, F., & Taxis, K. (2007). A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. Journal of Clinical Pharmacy and Therapeutics,32, 469–476.  https://doi.org/10.1111/j.1365-2710.2007.00849.x.CrossRefPubMedGoogle Scholar
  9. 9.
    Zaman Huri, H., & Chai Ling, L. (2013). Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health,13, 1192.  https://doi.org/10.1186/1471-2458-13-1192.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    García-Pérez, L.-E., Alvarez, M., Dilla, T., et al. (2013). Adherence to therapies in patients with type 2 diabetes. Diabetes Therapy, Research, Treatment and Education of Diabetes and Related Disorders,4, 175–194.  https://doi.org/10.1007/s13300-013-0034-y.CrossRefGoogle Scholar
  11. 11.
    Wong, E. L., Yam, C. H., Cheung, A. W., et al. (2011). Barriers to effective discharge planning: A qualitative study investigating the perspectives of frontline healthcare professionals. BMC Health Services Research,11, 242.  https://doi.org/10.1186/1472-6963-11-242.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Jacobs, B., Ir, P., Bigdeli, M., et al. (2012). Addressing access barriers to health services: An analytical framework for selecting appropriate interventions in low-income Asian countries. Health Policy Plan,27, 288–300.  https://doi.org/10.1093/heapol/czr038.CrossRefPubMedGoogle Scholar
  13. 13.
    Fonseca, V. A. (2009). Defining and characterizing the progression of type 2 diabetes. Diabetes Care,32(Suppl 2), S151–S156.  https://doi.org/10.2337/dc09-S301.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007). Sensitivity of patient outcomes to pharmacist interventions. Part I: Systematic review and meta-analysis in diabetes management. Annals of Pharmacotherapy,41, 1569–1582.  https://doi.org/10.1345/aph.1K151.CrossRefPubMedGoogle Scholar
  15. 15.
    Ali, M., Schifano, F., Robinson, P., et al. (2012). Impact of community pharmacy diabetes monitoring and education programme on diabetes management: A randomized controlled study. Diabetic Medicine,29, e326–e333.  https://doi.org/10.1111/j.1464-5491.2012.03725.x.CrossRefPubMedGoogle Scholar
  16. 16.
    Mossialos, E., Courtin, E., Naci, H., et al. (2015). From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management. Health Policy,119, 628–639.  https://doi.org/10.1016/j.healthpol.2015.02.007.CrossRefPubMedGoogle Scholar
  17. 17.
    Dhippayom, T., & Krass, I. (2015). Supporting self-management of type 2 diabetes: Is there a role for the community pharmacist? Patient Preference and Adherence,9, 1085–1092.  https://doi.org/10.2147/PPA.S88071.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review,84, 191–215.CrossRefGoogle Scholar
  19. 19.
    Walker, R. J., Smalls, B. L., Hernandez-Tejada, M. A., et al. (2014). Effect of diabetes self-efficacy on glycemic control, medication adherence, self-care behaviors, and quality of life in a predominantly low-income, minority population. Ethnicity and Disease,24, 349–355.PubMedGoogle Scholar
  20. 20.
    Indelicato, L., Dauriz, M., Santi, L., et al. (2017). Psychological distress, self-efficacy and glycemic control in type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases,27, 300–306.  https://doi.org/10.1016/j.numecd.2017.01.006.CrossRefPubMedGoogle Scholar
  21. 21.
    Perrin, N. E., Davies, M. J., Robertson, N., et al. (2017). The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: A systematic review and meta-analysis. Diabetic Medicine,34, 1508–1520.  https://doi.org/10.1111/dme.13448.CrossRefPubMedGoogle Scholar
  22. 22.
    Wändell, P. E. (2005). Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scandinavian Journal of Primary Health Care,23, 68–74.  https://doi.org/10.1080/02813430510015296.CrossRefPubMedGoogle Scholar
  23. 23.
    Dismuke, C. E., Hernandez-Tejada, M. A., & Egede, L. E. (2014). Relationship of serious psychological distress to quality of life in adults with diabetes. International Journal of Psychiatry in Medicine,48, 135–146.  https://doi.org/10.2190/PM.48.2.f.CrossRefPubMedGoogle Scholar
  24. 24.
    Donald, M., Dower, J., Coll, J. R., et al. (2013). Mental health issues decrease diabetes-specific quality of life independent of glycaemic control and complications: Findings from Australia’s living with diabetes cohort study. Health and Quality of Life Outcomes,11, 170.  https://doi.org/10.1186/1477-7525-11-170.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    NCD Risk Factor Collaboration (NCD-RisC). (2016). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. The Lancet London England,387, 1513–1530.  https://doi.org/10.1016/S0140-6736(16)00618-8.CrossRefGoogle Scholar
  26. 26.
    Lim, R. B. T., Zheng, H., Yang, Q., et al. (2013). Ethnic and gender specific life expectancies of the Singapore population, 1965 to 2009—converging, or diverging? BMC Public Health,13, 1012.  https://doi.org/10.1186/1471-2458-13-1012.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Mulimba, A. A. C., & Byron-Daniel, J. (2014). Motivational interviewing-based interventions and diabetes mellitus. British Journal of Nursing,23, 8–14.CrossRefGoogle Scholar
  28. 28.
    Motivational Interviewing: Empowering Patients to Change Behaviors. Retrieved March 18, 2018, from http://elearning.pharmacist.com/products/4313/motivational-interviewing-empowering-patients-to-change-behaviors.
  29. 29.
    Goldberg, D. P., Gater, R., Sartorius, N., et al. (1997). The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychological Medicine,27, 191–197.CrossRefGoogle Scholar
  30. 30.
    Luo, N., Chew, L. H., Fong, K. Y., et al. (2003). Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Quality of Life Research,12, 87–92.CrossRefGoogle Scholar
  31. 31.
    Hayes, A. F. (2013). Introduction to mediation, moderation and conditional process analysis: A regression based approach. New York: Guilford Press.Google Scholar
  32. 32.
    Co, M. A., Tan, L. S. M., Tai, E. S., et al. (2015). Factors associated with psychological distress, behavioral impact and health-related quality of life among patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications,29, 378–383.  https://doi.org/10.1016/j.jdiacomp.2015.01.009.CrossRefPubMedGoogle Scholar
  33. 33.
    Pereira, M. G., Pedras, S., Ferreira, G., & Machado, J. C. (2018). Differences, predictors, and moderators of therapeutic adherence in patients recently diagnosed with type 2 diabetes. Journal of Health Psychology.  https://doi.org/10.1177/1359105318780505.CrossRefPubMedGoogle Scholar
  34. 34.
    Hayes, A. F., & Montoya, A. K. (2017). A tutorial on testing, visualizing, and probing an interaction involving a multicategorical variable in linear regression analysis. Communication Methods and Measures,11, 1–30.  https://doi.org/10.1080/19312458.2016.1271116.CrossRefGoogle Scholar
  35. 35.
    Chew, B.-H., Vos, R., Mohd-Sidik, S., & Rutten, G. E. H. M. (2016). Diabetes-related distress, depression and distress-depression among adults with type 2 diabetes mellitus in Malaysia. PLoS ONE,11, e0152095.  https://doi.org/10.1371/journal.pone.0152095.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Rothman, R., Malone, R., Bryant, B., et al. (2003). Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. American Journal of Medical Quality,18, 51–58.  https://doi.org/10.1177/106286060301800202.CrossRefPubMedGoogle Scholar
  37. 37.
    Armour, C. L., Taylor, S. J., Hourihan, F., et al. (2004). Implementation and evaluation of Australian pharmacists’ diabetes care services. Journal of the American Pharmacists Association,44, 455–466.CrossRefGoogle Scholar
  38. 38.
    Lange, L. J., & Piette, J. D. (2005). Perceived health status and perceived diabetes control: Psychological indicators and accuracy. Journal of Psychosomatic Research,58, 129–137.  https://doi.org/10.1016/j.jpsychores.2004.08.004.CrossRefPubMedGoogle Scholar
  39. 39.
    Livneh, H., & Antonak, R. F. (2005). Psychosocial adaptation to chronic illness and disability: A primer for counselors. Journal of Counseling & Development,83, 12–20.  https://doi.org/10.1002/j.1556-6678.2005.tb00575.x.CrossRefGoogle Scholar
  40. 40.
    Al-Amer, R., Ramjan, L., Glew, P., & Salamonson, Y. (2015). Diagnosis of type 2 diabetes: The experience of Jordanian patients with co-existing depression. Issues in Mental Health Nursing,36, 231–238.  https://doi.org/10.3109/01612840.2014.960627.CrossRefPubMedGoogle Scholar
  41. 41.
    American Diabetes Association. (2018). Standards of medical care in diabetes—2018. Diabetes Care,41(Suppl. 1), S1–S159.Google Scholar
  42. 42.
    Harris, A. D., McGregor, J. C., Perencevich, E. N., et al. (2006). The use and interpretation of quasi-experimental studies in medical informatics. Journal of the American Medical Informatics Association JAMIA,13, 16–23.  https://doi.org/10.1197/jamia.M1749.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Geppert, C., Candilis, P., Baker, S., et al. (2014). Motivations of patients with diabetes to participate in research. AJOB Empirical Bioethics,5, 14–21.  https://doi.org/10.1080/23294515.2014.910282.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pharmacy, Faculty of ScienceNational University of SingaporeSingaporeSingapore
  2. 2.Unity NTUC FairPrice Co-operative LtdSingaporeSingapore
  3. 3.Choa Chu Kang Family ClinicSingaporeSingapore

Personalised recommendations